Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

REGNREGN
Showing 8 of 13 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in REGENERON PHARMACEUTICALS

JACOBS LEVY EQUITY MANAGEMENT, INC holds 256,503 shares of REGN (REGENERON PHARMACEUTICALS), worth $159.9M as of 2026-Q2. The position was increased (+19.8% shares). REGN represents 0.6% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$159.9M

Current Shares

256,503

Total Value Change

+$135.1M

Total Shares Change

+232,912

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
256,503
+19.8%
$159.9M0.6%$622.81
51
2026-Q1
Decreased
214,160
-19.2%
$165.5M0.7%$770.59
0
2025-Q4
Decreased
264,991
-8.0%
$204.5M0.8%$768.90
0
2025-Q3
Increased
287,881
+22.9%
$161.9M0.6%$559.40
52
2025-Q2
Increased
234,267
+313x
$123M0.5%$521.53
58
2025-Q1
Decreased
747
-11.8%
$473,7700.0%$629.11
0
2024-Q4
Decreased
847
-96.4%
$603,3440.0%$705.67
0
2024-Q3
Increased
23,591
+76.3%
$24.8M0.1%$1,041.41
43

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used